IL6 and pulmonary fibrosis: Aditionally, our analysis revealed that the increase in IL-6 at the 3-month evaluation represents a risk factor for lung fibrosis, while the risk of fibrosis in both timelines (3 months and 2 years) was found to also be proportional to the values of inflammatory markers (ESR and fibrinogen).